Biopharmaceutical News and Research

RSS
Continuous in vitro monitoring could lead to faster, more effective treatments for chronic conditions

Continuous in vitro monitoring could lead to faster, more effective treatments for chronic conditions

Eliminating tumors with engineered ‘off-the-shelf’ therapeutic T cells

Eliminating tumors with engineered ‘off-the-shelf’ therapeutic T cells

Researchers create a new mouse model for studying glioblastoma

Researchers create a new mouse model for studying glioblastoma

Altimmune reports positive results on intranasal COVID-19 vaccine candidate

Altimmune reports positive results on intranasal COVID-19 vaccine candidate

Scientists discover role of surface diffusion in protein transport

Scientists discover role of surface diffusion in protein transport

Molecular dynamic simulations may contribute to structure-based drug design

Molecular dynamic simulations may contribute to structure-based drug design

Study identifies new pathway to attack tumor cells

Study identifies new pathway to attack tumor cells

Discovery Of Antibody That Blocks Infection Of SARS-Cov-2

Discovery Of Antibody That Blocks Infection Of SARS-Cov-2

Antibodies Could Provide New Treatment For OCD

Antibodies Could Provide New Treatment For OCD

Identifying Potential Drugs Earlier In Discovery

Identifying Potential Drugs Earlier In Discovery

Avantor launches new Protein A Chromatography Resin – PROchievA – that provides supply chain flexibility and improves downstream purification performance for monoclonal antibodies (mAbs) production

Avantor launches new Protein A Chromatography Resin – PROchievA – that provides supply chain flexibility and improves downstream purification performance for monoclonal antibodies (mAbs) production

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.